Non-muscle invasive bladder cancer (NMIBC) is a type of bladder cancer that is confined to the innermost layers of the bladder wall. It is one of the most common forms of bladder cancer and typically affects older adults. Understanding this condition is important for early detection and effective treatment.

What Is Non-Muscle Invasive Bladder Cancer?

NMIBC is characterized by the growth of cancer cells on the inner lining of the bladder, without invading the muscular layer beneath. Because it remains localized, it often has a better prognosis than invasive bladder cancers. However, it can recur and sometimes progress to more advanced stages if not properly managed.

Types of NMIBC

  • Ta Tumors: Non-invasive papillary tumors that grow outward into the bladder lumen.
  • Carcinoma in situ (CIS): Flat, high-grade cancer cells that are confined to the bladder lining.

Symptoms and Diagnosis

Common symptoms include blood in the urine, frequent urination, and pain during urination. Diagnosis involves cystoscopy, where a thin camera is inserted into the bladder, and urine tests. Biopsies may also be taken to confirm the presence of cancer cells.

Treatment Options

Several treatments are available for NMIBC, aiming to remove or destroy cancerous cells and prevent recurrence. The choice of treatment depends on the tumor grade, size, and number.

Transurethral Resection of Bladder Tumor (TURBT)

This common procedure involves inserting a cystoscope through the urethra to remove tumors from the bladder lining. It is often the first step in treatment.

Intravesical Therapy

After TURBT, doctors may administer medications directly into the bladder. The most common is Bacillus Calmette-Guérin (BCG), which stimulates the immune system to attack remaining cancer cells. Chemotherapy drugs can also be used.

Follow-Up and Monitoring

Regular cystoscopies and urine tests are essential to monitor for recurrence. The frequency of follow-up depends on the initial tumor characteristics and response to treatment. Early detection of recurrence improves outcomes.

Conclusion

Non-muscle invasive bladder cancer is a manageable condition with early diagnosis and appropriate treatment. Advances in surgical techniques and intravesical therapies have improved patient outcomes. Ongoing monitoring is crucial to detect and treat recurrences promptly.